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Suspected 
Horse-to-Human 
Transmission of 
MRSA ST398
To the Editor: Methicillin-
resistant  Staphylococcus aureus 
(MRSA) is spreading worldwide 
among humans and animals, 
including horses. Many reports of 
MRSA colonization and infection 
in horses come from Canada and 
involve MRSA of sequence type 
(ST) 8, classiﬁ  ed by pulsed-ﬁ  eld gel 
electrophoresis (PFGE) as Canadian 
MRSA-5 or USA500. ST8 is thought 
to be a human epidemic clone that 
has adapted to horses (1). Another 
MRSA type, ST398, has recently 
begun spreading in Europe and 
North America and is associated with 
livestock (2). In the Netherlands, 
MRSA of ST8 (spa-type t064) and 
ST398 (spa-type t011), which belong 
to the livestock–associated CC398, 
predominate in clinical samples from 
horses (3). To date, human clinical 
infections with livestock–associated 
MRSA are uncommon in persons 
who have not had contact with pigs 
or calves (2). In this case study, we 
describe the suspected transmission of 
MRSA ST398 between a horse and a 
girl, which resulted in infection of the 
girl’s right foot.
In the Netherlands, a 16-year-
old girl with spinal muscular 
atrophy type II (wheelchair-bound 
and needing artiﬁ  cial  ventilation) 
sought treatment at a hospital for 
an infected wound on her right foot 
thought to be caused by an insect bite 
(online Appendix Figure, www.cdc.
gov/EID/content/17/6/1137-appF.
htm). The girl was treated as an 
outpatient. The infection did not 
respond to empirical treatment with 
clindamycin and ciproﬂ  oxacin. From 
the infected wound, a MRSA strain 
that was resistant to clindamycin, 
ciproﬂ   oxacin, erythromycin, genta-
micin, kanamycin, tetracycline, 
and trimethoprim/sulfonamide, and 
susceptible to rifampin and fusidic 
acid, was isolated 39 days after 
initial treatment. Identiﬁ  cation of the 
bacteria and susceptibility testing 
were performed by using Vitek 2 
(bioMérieux, Marcy l’Etoile, France). 
The girl did not have a history of 
hospital admission in other countries, 
nor contact with pigs or calves, but 
had had intensive contact with a foal. 
No information was available about 
hand hygiene practices the girl used 
after stroking the foal. 
Because the girl was a frequent 
visitor to the hospital, according 
to the national hospital MRSA 
guidelines, decolonization therapy 
was indicated. Before therapy began, 
her 3 household members and their 
animals (7 adult Friesian horses, 2 
dogs, and 2 cats) were screened for 
MRSA by enrichment culturing. Nasal 
swabs were taken from the animals; 
nasal, throat, and perineal samples 
were taken from the humans. MRSA 
with an identical susceptibility pattern 
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was isolated from a sample taken from 
the nares of the girl’s healthy Friesian 
foal. The foal had been hospitalized at 
a horse clinic 2 months earlier because 
of a wound infection and had been 
treated with antimicrobial drugs, but 
no samples had been taken from the 
horse’s wound at that time. All other 
screening samples were negative for 
MRSA. The girl’s wound healed after 
application of mupirocin ointment 
to the nares and perineum (3×/d for 
5 days), washing of the body with 
chlorhexidine shampoo (1×/d for 
5 days), and oral administration of 
fusidic acid and rifampin for 7 days; 
samples taken were negative for 
MRSA. The girl was advised not to 
touch the foal until it too was negative 
for MRSA. Without therapy, and 
within 3 months, the foal was negative 
for MRSA (conﬁ  rmed by 3 repeated 
negative cultures of nasal samples by 
enrichment culturing).
Isolates from the girl and the 
horse were further investigated by 
Martineau PCR targeting the tuf gene 
(4),  mecA PCR (5), ST398-speciﬁ  c 
PCR (6),  spa typing (7), and PFGE 
using  SmaI and Cfr9I as restriction 
enzymes (8). Both isolates were 
identiﬁ  ed  as  S. aureus, were mecA 
positive, belonged to ST398, were spa 
type t011, were nontypeable by PFGE 
using SmaI, and had indistinguishable 
PFGE patterns using Cfr9I.
Colonization of persons in contact 
with infected or colonized horses has 
been widely reported (1–3). Clinical 
MRSA infections of humans associated 
with horse contact, however, are rare 
and, to our knowledge, only 2 reports 
have been published. The ﬁ  rst report 
of a human infection came from 
Canada and concerned a veterinarian 
who had a tattoo site infection with 
Canadian MRSA-5, (ST8, SCCmec 
type IV, spa type t007) (9). Human 
skin infections with Canadian MRSA-
5 associated with horse contact were 
also reported from 3 persons who 
worked in a foal nursery (10). MRSA 
ST398  spa-type t011 are cultured 
regularly from equine samples at the 
horse clinic (3); therefore, the foal 
probably became colonized during its 
hospitalization. Livestock-associated 
MRSA infections are rare in humans 
in the region where the girl lives, 
and human-to-human transmission 
of MRSA ST398 is uncommon. 
In addition, the girl was severely 
handicapped and could not travel 
freely. Therefore, we theorize that the 
foal, which was stabled in a barn at 
her home, was the most likely source 
of the infection. It is also possible 
that the girl and the foal contracted 
MRSA from an unidentiﬁ  ed common 
source or that the foal was exposed 
by the girl, although this is less 
likely. Close collaboration between 
the pediatrician, infection control 
practitioner, veterinarians, and the 
human microbiologist was necessary 
to identify the suspected source of 
infection. 
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Screening for 
Pandemic (H1N1) 
2009 Virus among 
Hospital Staff, 
Spain
To the Editor: After the 
emergence of pandemic (H1N1) 2009 
virus, measures for its control were 
taken quickly (e.g., isolation of affected 
patients and use of gowns, gloves, 
and N95 respirators) when a clinical 
suspicion of pandemic inﬂ  uenza was 
established (1). One population group 
frequently exposed to this virus is 
health care staff. These circumstances 
prompted us to implement a screening 
program for the pandemic (H1N1) 
2009 virus among personnel working 
at our hospital in Marbella, Spain.
Costa del Sol Hospital is a 250-
bed, second-level center located on 
the Mediterranean coast. A proposal 
was made to staff working in the 
emergency and internal medicine 
areas that nasal and pharyngeal 
samples to identify the virus by real-
time PCR should be taken weekly 
over 12 consecutive weeks, from the 
third week of September 2009 to the 
third week of December. In addition 
to providing samples, each worker 
would be asked to complete a health-
status questionnaire regarding his 
or her vaccination record and the 
presence of signs or symptoms. Signs 
and symptoms to be reported in the 
questionnaires included fever, runny 
nose, painful swallowing, coughing, 
sore throat, diarrhea, vomiting, 
headaches, muscle pains, and general 
indisposition; 1 question also asked 
whether, during the previous week, a 
conﬁ  rmed diagnosis of inﬂ  uenza with 
a positive PCR for pandemic (H1N1) 
2009 virus had been made in the 
respondent’s household.
At the outset, 60 members of 
the hospital staff volunteered to 
participate. Those who missed >4 
sample tests, or >2 consecutive ones, 
were considered to have abandoned 
the study. Of the 36 staff members who 
completed the study, 27 were women 
(75%). The participants’ average age 
was 37 years (CI 95%: 34.8–39.4). 
Sixteen were doctors, 16 were nurses, 
2 were nursing auxiliary staff, and 2 
were hospital orderlies. During the 
monitoring period, 5 (13%) subjects 
exhibited coughing, 7 (20%) had runny 
noses, 3 (8%) experienced painful 
swallowing, 6 (16%) had headaches, 
and 1 (2%) felt generally unwell. 
Nearly 75% stated they washed their 
hands with antiseptic lotion >20×/d. 
Three workers were vaccinated 
against seasonal and pandemic 
inﬂ  uenza, while only 1 was vaccinated 
against pandemic (H1N1) 2009 alone. 
None took oseltamivir. Five positive 
samples were identiﬁ  ed (13.8% of the 
study population) being obtained from 
four doctors and one nurse, all women. 
The 4 doctors had signs and symptoms 
for 24–48 hours consisting of fever, 
general indisposition, and coughing; 
none of the 4 required hospitalization. 
The nurse was a woman 26 years of 
age with no inﬂ  uenza symptoms and 
with a positive PCR result on week 5. 
None of these 5 workers had received 
any inﬂ  uenza vaccination.
Three workers reported that a 
diagnosis of pandemic (H1N1) 2009 
inﬂ  uenza had been made with respect 
to a member of their household, but 
none of the workers had a positive 
PCR result. The distribution of positive 
PCR results in our hospital during the 
study is shown in the Figure.
It had previously been hypo-
thesized that the incidence of 
asymptomatic cases would be higher 
than the incidence of symptomatic 
cases (2) overall in persons with 
high exposure (3). However, among 
the study population, only 1 person 
with positive PCR results was 
asymptomatic.
Health care workers may have 
been exposed in a gradual manner 
from the beginning of the outbreak 
to a few symptomatic forms, which 
would explain why so few of them 
were actually affected. Of the workers 
in the emergency department who 
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Figure. Number of PCR-conﬁ  rmed cases of pandemic (H1N1) 2009 virus infection in the 
emergency department (PCR-ER), hospitalized patients (PCR-HP), and participants (PCR-
HS) in a study of screening for pandemic (H1N1) 2009 virus among health care workers, 
Spain, September–December 2009.